Generation Bio Co. (GBIO)
NASDAQ: GBIO
· Real-Time Price · USD
5.98
-0.02 (-0.33%)
At close: Sep 29, 2025, 3:59 PM
5.87
-1.84%
After-hours: Sep 29, 2025, 07:20 PM EDT
-0.33% (1D)
| Bid | 5.5 |
| Market Cap | 40.28M |
| Revenue (ttm) | 21.23M |
| Net Income (ttm) | -72.42M |
| EPS (ttm) | -10.84 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -2.08 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 6.48 |
| Volume | 43,894 |
| Avg. Volume (20D) | 346,874 |
| Open | 6.11 |
| Previous Close | 6.00 |
| Day's Range | 5.90 - 6.23 |
| 52-Week Range | 3.00 - 27.40 |
| Beta | 2.49 |
| Ex-Dividend Date | n/a |
About GBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGeneration Bio Co. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+63.21%
Generation Bio shares are trading higher after the...
Unlock content with
Pro Subscription
1 month ago
+0.25%
Generation Bio shares are trading higher after the company announced new data demonstrating that its cell-targeted lipid nanoparticle system selectively delivered siRNA to T cells in non-human primates.
